These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 35441886)
1. An approach to p32/gC1qR/HABP1: a multifunctional protein with an essential role in cancer. Egusquiza-Alvarez CA; Robles-Flores M J Cancer Res Clin Oncol; 2022 Aug; 148(8):1831-1854. PubMed ID: 35441886 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of Multifunctional Protein p32/C1QBP Promotes Cytostatic Effects in Colon Cancer Cells by Altering Mitogenic Signaling Pathways and Promoting Mitochondrial Damage. Egusquiza-Alvarez CA; Moreno-Londoño AP; Alvarado-Ortiz E; Ramos-Godínez MDP; Sarabia-Sánchez MA; Castañeda-Patlán MC; Robles-Flores M Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473963 [TBL] [Abstract][Full Text] [Related]
3. Complement protein C1q stimulates hyaluronic acid degradation Balduit A; Vidergar R; Zacchi P; Mangogna A; Agostinis C; Grandolfo M; Bottin C; Salton F; Confalonieri P; Rocca A; Zanconati F; Confalonieri M; Kishore U; Ghebrehiwet B; Bulla R Front Immunol; 2023; 14():1151194. PubMed ID: 37334363 [TBL] [Abstract][Full Text] [Related]
4. Role of C1QBP/p32 and its Therapeutic Potential in Breast Carcinoma and other Cancers. Matsumoto K; Bay BH Curr Med Chem; 2021; 28(25):5048-5065. PubMed ID: 33390103 [TBL] [Abstract][Full Text] [Related]
5. Multi-functional, multicompartmental hyaluronan-binding protein 1 (HABP1/p32/gC1qR): implication in cancer progression and metastasis. Saha P; Datta K Oncotarget; 2018 Feb; 9(12):10784-10807. PubMed ID: 29535843 [TBL] [Abstract][Full Text] [Related]
6. gC1qR: A New Target for Cancer Immunotherapy. Lei Y; Li X; Qin D; Zhang Y; Wang Y Front Immunol; 2023; 14():1095943. PubMed ID: 36776869 [TBL] [Abstract][Full Text] [Related]
7. Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation. Fogal V; Richardson AD; Karmali PP; Scheffler IE; Smith JW; Ruoslahti E Mol Cell Biol; 2010 Mar; 30(6):1303-18. PubMed ID: 20100866 [TBL] [Abstract][Full Text] [Related]
8. The C1q and gC1qR axis as a novel checkpoint inhibitor in cancer. Ghebrehiwet B; Zaniewski M; Fernandez A; DiGiovanni M; Reyes TN; Ji P; Savitt AG; Williams JL; Seeliger MA; Peerschke EIB Front Immunol; 2024; 15():1351656. PubMed ID: 38711524 [TBL] [Abstract][Full Text] [Related]
10. Hyaluronan-binding protein 1 (HABP1/p32/gC1qR) induces melanoma cell migration and tumor growth by NF-kappa B dependent MMP-2 activation through integrin α(v)β(3) interaction. Prakash M; Kale S; Ghosh I; Kundu GC; Datta K Cell Signal; 2011 Oct; 23(10):1563-77. PubMed ID: 21627988 [TBL] [Abstract][Full Text] [Related]
11. gC1qR/HABP1/p32 Is a Potential New Therapeutic Target Against Mesothelioma. Peerschke E; Stier K; Li X; Kandov E; de Stanchina E; Chang Q; Xiong Y; Manova-Todorova K; Fan N; Barlas A; Ghebrehiwet B; Adusumilli PS Front Oncol; 2020; 10():1413. PubMed ID: 32903438 [TBL] [Abstract][Full Text] [Related]
12. p32 protein levels are integral to mitochondrial and endoplasmic reticulum morphology, cell metabolism and survival. Hu M; Crawford SA; Henstridge DC; Ng IH; Boey EJ; Xu Y; Febbraio MA; Jans DA; Bogoyevitch MA Biochem J; 2013 Aug; 453(3):381-91. PubMed ID: 23692256 [TBL] [Abstract][Full Text] [Related]
13. Loss of Mucosal p32/gC1qR/HABP1 Triggers Energy Deficiency and Impairs Goblet Cell Differentiation in Ulcerative Colitis. Sünderhauf A; Hicken M; Schlichting H; Skibbe K; Ragab M; Raschdorf A; Hirose M; Schäffler H; Bokemeyer A; Bettenworth D; Savitt AG; Perner S; Ibrahim S; Peerschke EI; Ghebrehiwet B; Derer S; Sina C Cell Mol Gastroenterol Hepatol; 2021; 12(1):229-250. PubMed ID: 33515804 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of hyaluronan-binding protein 1 (HABP1/p32/gC1qR) in HepG2 cells leads to increased hyaluronan synthesis and cell proliferation by up-regulation of cyclin D1 in AKT-dependent pathway. Kaul R; Saha P; Saradhi M; Prasad RL; Chatterjee S; Ghosh I; Tyagi RK; Datta K J Biol Chem; 2012 Jun; 287(23):19750-64. PubMed ID: 22451658 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of Multifunctional Protein p32 Promotes a Malignant Phenotype in Colorectal Cancer Cells. Egusquiza-Alvarez CA; Castañeda-Patlán MC; Albarran-Gutierrez S; Gonzalez-Aguilar H; Moreno-Londoño AP; Maldonado V; Melendez-Zajgla J; Robles-Flores M Front Oncol; 2021; 11():642940. PubMed ID: 34136383 [TBL] [Abstract][Full Text] [Related]
17. Mitochondrial protein p32/HAPB1/gC1qR/C1qbp is required for efficient respiratory syncytial virus production. Hu M; Li HM; Bogoyevitch MA; Jans DA Biochem Biophys Res Commun; 2017 Aug; 489(4):460-465. PubMed ID: 28576489 [TBL] [Abstract][Full Text] [Related]
18. Antibody neutralization of cell-surface gC1qR/HABP1/SF2-p32 prevents lamellipodia formation and tumorigenesis. Kim BC; Hwang HJ; An HT; Lee H; Park JS; Hong J; Ko J; Kim C; Lee JS; Ko YG Oncotarget; 2016 Aug; 7(31):49972-49985. PubMed ID: 27363031 [TBL] [Abstract][Full Text] [Related]
19. Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles. Hunt H; Simón-Gracia L; Tobi A; Kotamraju VR; Sharma S; Nigul M; Sugahara KN; Ruoslahti E; Teesalu T J Control Release; 2017 Aug; 260():142-153. PubMed ID: 28603028 [TBL] [Abstract][Full Text] [Related]
20. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation. Petersen-Mahrt SK; Estmer C; Ohrmalm C; Matthews DA; Russell WC; Akusjärvi G EMBO J; 1999 Feb; 18(4):1014-24. PubMed ID: 10022843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]